Ignite Creation Date:
2025-12-25 @ 5:08 AM
Ignite Modification Date:
2025-12-26 @ 4:12 AM
Study NCT ID:
NCT05541627
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-09-18
First Post:
2022-09-13
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Study to Evaluate AB-1001 Striatal Administration in Adults With Early Manifest Huntington's Disease
Sponsor:
Brainvectis, a subsidiary of Asklepios BioPharmaceutical, Inc. (AskBio)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-10-12
Start Date Type:
ACTUAL
Primary Completion Date:
2024-04-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2028-04
Completion Date Type:
ESTIMATED
First Submit Date:
2022-09-13
First Submit QC Date:
None
Study First Post Date:
2022-09-15
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-09-12
Last Update Post Date:
2025-09-18
Last Update Post Date Type:
ESTIMATED